Physician
Radiation Oncology
Dr. Nina A. Mayr, MD
|
|
Give Review
Nina Mayr is an expert in the field of Radiation Oncology. Nina Mayr is a published MD. She published 63 publications, including: 'Stereotactic body radiotherapy for pancreatic cancer: recent progress and future directions.' Nina Mayr is registered with Medicare.
Publications
- Comparison and Consensus Guidelines for Delineation of Clinical Target Volume for CT- and MR-Based Brachytherapy in Locally Advanced Cervical Cancer.
- Combination of stereotactic ablative body radiation with targeted therapies.
- Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical Cancer for outcome prediction.
- ACR Appropriateness Criteria® Advanced Stage Endometrial Cancer.
- The tolerance of gastrointestinal organs to stereotactic body radiation therapy: what do we know so far?
- Assessment of interpatient heterogeneity in tumor radiosensitivity for nonsmall cell lung Cancer using tumor-volume variation data.
- Emerging applications of stereotactic body radiotherapy.
- Understanding patient satisfaction ratings for radiology services.
- Acr appropriateness Criteria management of vaginal Cancer.
- In memoriam, david h. Hussey, MD.
- ACR Appropriateness Criteria® Management of Locoregionally Advanced Squamous Cell Carcinoma of the Vulva.
- Image Guided Radiation Therapy (IGRT) Technologies for Radiation Therapy Localization and Delivery.
- Emerging role of stereotactic body radiotherapy in the treatment of pancreatic Cancer.
- Serious Complications Associated with Stereotactic Ablative Radiotherapy and Strategies to Mitigate the Risk.
- Characterizing at-Risk Voxels by Using Perfusion Magnetic Resonance Imaging for Cervical Cancer during Radiotherapy.
- A generalized linear-quadratic model incorporating reciprocal time pattern of radiation damage repair.
- Characterizing Tumor Heterogeneity with Functional Imaging and Quantifying High-Risk Tumor Volume for Early Prediction of Treatment Outcome: Cervical Cancer as a Model.
- ACR Appropriateness Criteria® role of adjuvant therapy in the management of early stage cervical Cancer.
- The role of local therapy in the management of lung and liver oligometastases.
- ACR Appropriateness Criteria® on Advanced Cervical Cancer Expert Panel on Radiation Oncology-Gynecology.
- Sequential magnetic resonance imaging of cervical Cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiati...
- Stereotactic radiosurgery alone for patients with 1-4 radioresistant brain metastases.
- Reporting of true spinal cord dose is encouraged for stereotactic body radiation therapy for spinal tumors. In regard to Sahgal et al. (Int J Radiat Oncol Biol Phys 20...
- Stereotactic body radiation therapy (SBRT) for genitourinary malignancies.
- A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy.
- Temporal analysis of tumor heterogeneity and volume for cervical Cancer treatment outcome prediction: preliminary evaluation.
- Longitudinal changes in tumor perfusion pattern during the radiation therapy course and its clinical impact in cervical Cancer.
- Stereotactic body radiation therapy for hepatocellular carcinoma.
- Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung Cancer--updates of radiobiology, techniques, and clinical outc...
- Stereotactic body radiation therapy for spinal metastases.
- Translating response during therapy into ultimate treatment outcome: a personalized 4-dimensional MRI tumor volumetric regression approach in cervical Cancer.
- Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical Cancer.
- Stereotactic radiosurgery with or without whole brain radiotherapy for patients with a single radioresistant brain metastasis.
- Predicting outcomes in cervical Cancer: a kinetic model of tumor regression during radiation therapy.
- Synergistic effects of hemoglobin and tumor perfusion on tumor control and survival in cervical Cancer.
- In regard to Hoppe et al. (Int J Radiat Oncol Biol Phys 2008;72:1283-1286).
- Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical Cancer.
- Synthesizing knowledge in the classroom.
- Hypofractionation regimens for stereotactic radiotherapy for large brain tumors.
- MRI for cervical Cancer not only correlates with tumor hypoxia, but also predicts ultimate outcome: in regard to Lim et al. (Int J Radiat Oncol Biol Phys 2008;70:126-1...
- Serial therapy-induced changes in tumor shape in cervical Cancer and their impact on assessing tumor volume and treatment response.
- Cranial nerve involvement in nasopharyngeal carcinoma: response to radiotherapy and its clinical impact.
- Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
- Central nervous system tumor: advance imaging and multispecialty approach.
- Tumor imaging: radiation oncology perspective.
- PET-CT for tumor delineation: in regard to Heron et al. (Int J Radiat Oncol Biol Phys 2004;60:1419-1424).
- Tumor hypoxia versus blood flow: In regard to Lehtio et al. (Int J Radiat Oncol Biol Phys 2004;59:971-982).
- Modeling prostate Cancer: in regards to Nahum et al. (Int J Radiat Oncol Biol Phys 2003;57:391-401).
- Brachytherapy management of the retroverted uterus using ultrasound-guided implant applicator placement.
- Interobserver variation in cervical Cancer tumor delineation for image-based radiotherapy planning among and within different specialties.
- Request form history, clinical indication, and yield of brain magnetic resonance studies.
- Does prone positioning reduce small bowel dose in pelvic radiation with intensity-modulated radiotherapy for gynecologic Cancer?
- MR fluid sign in osteoporotic vertebral fracture.
- Protracted radiotherapy treatment duration in medulloblastoma.
- Curative radiotherapy for primary orbital lymphoma.
- Pitfalls of radiation survey after brachytherapy implant removal preceding Tl-201 study.
- Intracranial ependymomas: an analysis of prognostic factors and patterns of failure.
- Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
- Radiation-induced changes in MR signal intensity and contrast enhancement of lumbosacral vertebrae: do changes occur only inside the radiation therapy field?
- Method and timing of tumor volume measurement for outcome prediction in cervical Cancer using magnetic resonance imaging.
- Imaging across the Life Span: Innovations in Imaging and Therapy for Gynecologic Cancer.
- Stereotactic body radiotherapy for pancreatic Cancer: recent progress and future directions.
Schools
LudwigMaximiliansUniversitaet Munchen Fachbereich Medizin
University Ia
Conditions Treated
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
University of Iowa Hospitals and Clinics -
Ludwig Maximilian University of Munich Faculty of Medicine
Hospital
-
Ohio State University Wexner Medical Center
Drug Facts
| NPI NUMBER | 1952409773 | |
| NPPES Provider LastName | MAYR | |
| NPPES Provider FirstName | NINA | |
| NPPES Provider ZIPCode | 981956043 | |
| NPPES Provider State | WA | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 41.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1952409773 |
| Last Name Of The Provider | MAYR |
| First Name Of The Provider | NINA |
| View All |
Similar Doctors
|
Jesse Alexander |
|
|
Dr. Timothy P. Mate, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick Jewell, MD |
|
|
Dr. Waylene A. Wang, MD |
|
|
Dr. Andrew D. Trister, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tobias R. Chapman, MD |
|
|
Dr. Benjamin L. King, MD |